Insmed | INSM - Costo Del Venduto

Prezzo Delle Azioni
148.23
Cambio Giornaliero
-5.17 -3.37%
Mensile
2.51%
Annuale
111.15%
Q2 Previsione
150.58




Costo Del Venduto Cambiamento Data
BioMarin Pharmaceutical USD 161.56M 16.62M 2025-12
Cytokinetics USD 99.23M 13.32M 2025-09
Gilead Sciences USD 1.62B 50M 2025-12
Heron Therapeutics USD 11.12M 795K 2025-12
Insmed USD 46.16M 15.25M 2025-12
Novartis USD 3.54B 7M 2025-12
Regeneron Pharmaceuticals USD 584.6M 63M 2025-12
Sarepta Therapeutics USD 399.38M 247.93M 2025-12
Ultragenyx Pharmaceutical USD 29M 1.01M 2025-12
Vertex Pharmaceuticals USD 466M 51.2M 2025-12